Treatment outcomes by histology in REVEL: A randomized phase III trial of Ramucirumab plus docetaxel for advanced non-small cell lung cancer

Bibliographic Details
Title: Treatment outcomes by histology in REVEL: A randomized phase III trial of Ramucirumab plus docetaxel for advanced non-small cell lung cancer
Authors: Paz-Ares, Luis G., Pérol, Maurice, Ciuleanu, Tudor-Eliade, Kowalyszyn, Ruben Dario, Reck, Martin, Lewanski, Conrad R., Syrigos, Konstantinos, Arrieta, Oscar, Prabhash, Kumar, Park, Keunchil, Pikiel, Joanna, Göksel, Tuncay, Lee, Pablo, Zimmermann, Anna, Carter, Gebra Cuyun, Alexandris, Ekaterine, Garon, Edward B.
Source: In Lung Cancer October 2017 112:126-133
Database: ScienceDirect
More Details
ISSN:01695002
DOI:10.1016/j.lungcan.2017.05.021
Published in:Lung Cancer
Language:English